Foot & Ankle Specialists of Nevada is now accepting appointments for Erchonia’s new LunulaLaser to target Onychomycosis. The FDA-approved, non-invasive LunulaLaser targets the fungus and stimulate an average of 6.1 mm* new clear nail growth at 6 months. Dr. Anthony Ricciardi comments, “Onychomycowidespreadde spread condition that affects up to 10% of the world’s population. Erchonia’s LunulaLaser is ideal treatment because it offers effective, pain-free, non-thermal treatment—without side effects or dangerous smoke plumes as other hot lasers used to treat onychomycosis. LunulaLaser consists of (4) weekly treatments 12 minute treatments. Erchonia’s LunulaLaser received FDA-clearance based on a double-blind, randomized, multi-site and placebo-controlled clinical trial. The LunulaLaser clinical trial proved 89% of patients respond to treatment. For more information or to schedule a LunulaLaser consultation, please use our contact form or call (702) 213-9093.